FDA Inspection 1265837 — Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Cheng Yi Pharmaceutical Co., Ltd. on March 7, 2025 in Wenzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 7, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wenzhou (China)